Engineering an anti-Stx2 antibody to control severe infections of EHEC O157:H7

Immunology Letters

Volumn 121, Issue 2, 2008, Pages 110-115

  Ma, Ying ^a,b   Mao, Xuhu ^a   Li, Jun ^a   Li, Haixia ^a   Feng, Youjun ^b   Chen, Hongzhang ^a   Luo, Ping ^a   Gu, Jiang ^a   Yu, Shu ^a   Zeng, Hao ^a   Guo, Gang ^a   Yang, Kang ^a   Zou, Quanming ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b INSTITUTE OF MICROBIOLOGY   (China)

Author keywords

EHEC O157:H7; scFv; Shiga toxin 2 (Stx2)

Indexed keywords

COMPLEMENTARY DNA; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 1A5; MONOCLONAL ANTIBODY 5C11; MONOCLONAL ANTIBODY 5F3; MONOCLONAL ANTIBODY IA4; MONOCLONAL ANTIBODY STX2; UNCLASSIFIED DRUG; VEROTOXIN 2; VERTOXIN 2A; VERTOXIN 2B;

ANIMAL CELL; ANTIBODY ENGINEERING; ARTICLE; CONTROLLED STUDY; ENTEROHEMORRHAGIC ESCHERICHIA COLI; ESCHERICHIA COLI O157; GENE EXPRESSION; HEMOLYTIC UREMIC SYNDROME; HEMORRHAGIC COLITIS; HUMAN; HUMAN CELL; IMMUNOGENICITY; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, MONOCLONAL; B-LYMPHOCYTES; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI O157; GENETIC ENGINEERING; HEMOLYTIC-UREMIC SYNDROME; HUMANS; HYBRIDOMAS; IMMUNIZATION, PASSIVE; IMMUNOGLOBULIN VARIABLE REGION; MICE; PROTEIN CONFORMATION; RECOMBINANT FUSION PROTEINS; SHIGA TOXIN 2; SPECIES SPECIFICITY;

EID: 57449109700     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2008.09.008     Document Type: Article

References (19)

1. Clarke S.C. Diarrhoeagenic Escherichia coli-an emerging problem?. Diagn Microbiol Infect Dis 41 (2001) 93-98
2. Karmali M.A. Infection by Shiga toxin-producing Escherichia coli: an overview. Mol Biotechnol 26 (2004) 117-122
3. Yamamoto J., Ishikawa A., Miyamoto M., Nomura T., Uchimura M., and Koiwai K. Outbreak of enterohemorrhagic Escherichia coli O157 mass infection caused by "whole roasted cow". Jpn J Infect Dis 54 (2001) 88-89
4. Spears K.J., Roe A.J., and Gally D.L. A comparison of enteropathogenic and enterohaemorrhagic Escherichia coli pathogenesis. FEMS Microbiol Lett 255 (2006) 187-202
5. Noel J.M., and Boedeker E.C. Enterohemorrhagic Escherichia coli: a family of emerging pathogens. Dig Dis 15 (1997) 67-91
6. Gunzer F., Hennig-Pauka I., Waldmann K.H., Sandhoff R., Grone H.J., Kreipe H.H., et al. Gnotobiotic piglets develop thrombotic microangiopathy after oral infection with enterohemorrhagic Escherichia coli. Am J Clin Pathol 118 (2002) 364-375
7. Sheoran A.S., Chapman S., Singh P., Donohue-Rolfe A., and Tzipori S. Stx2-specific human monoclonal antibodies protect mice against lethal infection with Escherichia coli expressing Stx2 variants. Infect Immun 71 (2003) 3125-3130
8. Tzipori S., Sheoran A., Akiyoshi D., Donohue-Rolfe A., and Trachtman H. Antibody therapy in the management of Shiga toxin-induced hemolytic uremic syndrome. Clin Microbiol Rev 17 (2004) 926-941 [table of contents]
9. Boerlin P., McEwen S.A., Boerlin-Petzold F., Wilson J.B., Johnson R.P., and Gyles C.L. Associations between virulence factors of Shiga toxin-producing Escherichia coli and disease in humans. J Clin Microbiol 37 (1999) 497-503
10. Ritchie J.M., Thorpe C.M., Rogers A.B., and Waldor M.K. Critical roles for stx2, eae, and tir in enterohemorrhagic Escherichia coli-induced diarrhea and intestinal inflammation in infant rabbits. Infect Immun 71 (2003) 7129-7139
11. Creydt V.P., Silberstein C., Zotta E., and Ibarra C. Cytotoxic effect of Shiga toxin-2 holotoxin and its B subunit on human renal tubular epithelial cells. Microbes Infect 8 (2006) 410-419
12. Sheoran A.S., Chapman-Bonofiglio S., Harvey B.R., Mukherjee J., Georgiou G., Donohue-Rolfe A., et al. Human antibody against Shiga toxin 2 administered to piglets after the onset of diarrhea due to Escherichia coli O157:H7 prevents fatal systemic complications. Infect Immun 73 (2005) 4607-4613
13. Marcato P., Mulvey G., Read R.J., Vander Helm K., Nation P.N., and Armstrong G.D. Immunoprophylactic potential of cloned Shiga toxin 2 B subunit. J Infect Dis 183 (2001) 435-443
14. Mukherjee J., Chios K., Fishwild D., Hudson D., O'Donnell S., Rich S.M., et al. Human Stx2-specific monoclonal antibodies prevent systemic complications of Escherichia coli O157:H7 infection. Infect Immun 70 (2002) 612-619
15. Donohue-Rolfe A., Kondova I., Mukherjee J., Chios K., Hutto D., and Tzipori S. Antibody-based protection of gnotobiotic piglets infected with Escherichia coli O157:H7 against systemic complications associated with Shiga toxin 2. Infect Immun 67 (1999) 3645-3648
16. Johansen M., Andresen L.O., Thomsen L.K., Busch M.E., Wachmann H., Jorsal S.E., et al. Prevention of edema disease in pigs by passive immunization. Can J Vet Res 64 (2000) 9-14
17. Nakao H., Kiyokawa N., Fujimoto J., Yamasaki S., and Takeda T. Monoclonal antibody to Shiga toxin 2 which blocks receptor binding and neutralizes cytotoxicity. Infect Immun 67 (1999) 5717-5722
18. Kimura T., Tani S., Motoki M., and Matsumoto Y. Role of Shiga toxin 2 (Stx2)-binding protein, human serum amyloid P component (HuSAP), in Shiga toxin-producing Escherichia coli infections: assumption from in vitro and in vivo study using HuSAP and anti-Stx2 humanized monoclonal antibody TMA-15. Biochem Biophys Res Commun 305 (2003) 1057-1060
19. Feng Y., Zheng F., Pan X., Sun W., Wang C., Dong Y., et al. Existence and characterization of allelic variants of Sao, a newly identified surface protein from Streptococcus suis. FEMS Microbiol Lett 275 (2007) 80-88